ATE335080T1 - Rekombinante proteine abgeleitet von hgf und msp - Google Patents

Rekombinante proteine abgeleitet von hgf und msp

Info

Publication number: ATE335080T1
Authority: AT; Austria
Prior art keywords: recombinant proteins; msp; hgf; proteins derived; deriving
Prior art date: 1998-01-30

Application number

AT99903681T

Other languages

English (en)

Inventor

Enzo Medico

Paolo Michieli

Chiara Collesi

Gianfranco Caselli

Paolo Comoglio

Original Assignee

Dompe Pha R Ma Spa Res & Mfg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-30

Filing date

1999-01-27

Publication date

2006-08-15

1999-01-27 Application filed by Dompe Pha R Ma Spa Res & Mfg filed Critical Dompe Pha R Ma Spa Res & Mfg

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE335080T1 publication Critical patent/ATE335080T1/de

Links

102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 3
108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 3
239000002246 antineoplastic agent Substances 0.000 abstract 2
230000006907 apoptotic process Effects 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1
229940044683 chemotherapy drug Drugs 0.000 abstract 1
229940127089 cytotoxic agent Drugs 0.000 abstract 1
230000034994 death Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000003102 growth factor Substances 0.000 abstract 1
238000011275 oncology therapy Methods 0.000 abstract 1
230000006798 recombination Effects 0.000 abstract 1
238000005215 recombination Methods 0.000 abstract 1
231100000331 toxic Toxicity 0.000 abstract 1
230000002588 toxic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT99903681T 1998-01-30 1999-01-27 Rekombinante proteine abgeleitet von hgf und msp ATE335080T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT98MI000179A ITMI980179A1 (it)	1998-01-30	1998-01-30	Proteine ricombinanti derivate da hgf e msp

Publications (1)

Publication Number	Publication Date
ATE335080T1 true ATE335080T1 (de)	2006-08-15

Family

ID=11378771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99903681T ATE335080T1 (de)	1998-01-30	1999-01-27	Rekombinante proteine abgeleitet von hgf und msp

Country Status (14)

Country	Link
US (1)	US6551991B1 (de)
EP (1)	EP1049778B1 (de)
JP (1)	JP4478329B2 (de)
AT (1)	ATE335080T1 (de)
AU (1)	AU740490B2 (de)
CA (1)	CA2319211C (de)
DE (1)	DE69932592T2 (de)
ES (1)	ES2270581T3 (de)
HU (1)	HU226717B1 (de)
IL (2)	IL137564A0 (de)
IT (1)	ITMI980179A1 (de)
NZ (1)	NZ506005A (de)
WO (1)	WO1999038967A2 (de)
ZA (1)	ZA99723B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040138120A1 (en) *	2002-10-07	2004-07-15	Genentech, Inc.	Hepatocyte growth factor variants
EP1642586A4 (de) *	2003-06-06	2009-06-17	Kringle Pharma Inc	Zellhaltige zubereitungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5350836A (en) *	1989-10-12	1994-09-27	Ohio University	Growth hormone antagonists
ATE222603T1 (de) *	1992-05-18	2002-09-15	Genentech Inc	Hepatozytwachstumfaktor variante
WO1993023550A2 (en) *	1992-05-18	1993-11-25	Genentech, Inc.	Activation of oligomerizing receptors by using fused receptor ligands
CA2144081C (en)	1992-09-16	2004-11-30	Filip Roos	Protection against liver damage by hgf

1998
- 1998-01-30 IT IT98MI000179A patent/ITMI980179A1/it unknown
1999
- 1999-01-27 AT AT99903681T patent/ATE335080T1/de not_active IP Right Cessation
- 1999-01-27 US US09/600,991 patent/US6551991B1/en not_active Expired - Fee Related
- 1999-01-27 HU HU0104598A patent/HU226717B1/hu not_active IP Right Cessation
- 1999-01-27 AU AU24245/99A patent/AU740490B2/en not_active Ceased
- 1999-01-27 ES ES99903681T patent/ES2270581T3/es not_active Expired - Lifetime
- 1999-01-27 DE DE69932592T patent/DE69932592T2/de not_active Expired - Lifetime
- 1999-01-27 CA CA2319211A patent/CA2319211C/en not_active Expired - Fee Related
- 1999-01-27 NZ NZ506005A patent/NZ506005A/xx unknown
- 1999-01-27 EP EP99903681A patent/EP1049778B1/de not_active Expired - Lifetime
- 1999-01-27 IL IL13756499A patent/IL137564A0/xx active IP Right Grant
- 1999-01-27 JP JP2000529427A patent/JP4478329B2/ja not_active Expired - Lifetime
- 1999-01-27 WO PCT/EP1999/000478 patent/WO1999038967A2/en not_active Ceased
- 1999-01-29 ZA ZA9900723A patent/ZA99723B/xx unknown
2000
- 2000-07-27 IL IL137564A patent/IL137564A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1049778B1 (de)	2006-08-02
HUP0104598A1 (hu)	2002-03-28
IL137564A0 (en)	2001-07-24
JP2002501745A (ja)	2002-01-22
CA2319211C (en)	2010-10-26
CA2319211A1 (en)	1999-08-05
US6551991B1 (en)	2003-04-22
WO1999038967A2 (en)	1999-08-05
DE69932592T2 (de)	2007-08-09
HU226717B1 (en)	2009-07-28
WO1999038967A3 (en)	1999-09-16
AU740490B2 (en)	2001-11-08
AU2424599A (en)	1999-08-16
ES2270581T3 (es)	2007-04-01
HUP0104598A3 (en)	2003-09-29
EP1049778A2 (de)	2000-11-08
NZ506005A (en)	2003-06-30
IL137564A (en)	2007-06-17
ITMI980179A1 (it)	1999-07-30
ZA99723B (en)	1999-07-29
DE69932592D1 (de)	2006-09-14
JP4478329B2 (ja)	2010-06-09

Similar Documents

Publication	Publication Date	Title
BR0007527A (pt)	2001-12-04	Fenilfenantridinas com atividade inibitória depde-iv
FI972086A7 (fi)	1997-05-15	Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
DK0653911T3 (da)	2000-10-02	Fremgangsmåder til inaktivering af bakterier i blodpræparater med 8-methoxypsoralen
BR0009670A (pt)	2002-01-15	Métodos de induzir morte de células de câncer e regressão de tumor
BR0315688A (pt)	2005-09-06	Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
DE69725293D1 (de)	2003-11-06	N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
ATE63748T1 (de)	1991-06-15	Enzymwiderstandsfaehige immunomodulatorische peptide.
ATE233735T1 (de)	2003-03-15	Neue phenanthridine
TR199903331T2 (xx)	2000-06-21	Farnesil protein transferas engelleyicileri.
DE69533551D1 (de)	2004-10-28	Camptothecin arzneimittelkombinationen mit verringerten nebenwirkungen
TR200101549T2 (tr)	2001-11-21	p53-Familyasından bir proteinin yapısal kararlılığının canlandırılmasına yönelik metotlar.
DK0661987T3 (da)	1998-09-14	Morphogeninduceret leverregeneration
ATE311853T1 (de)	2005-12-15	Verwendung von krillenzymen zur behandlung von zahnbelag
DE60008143D1 (de)	2004-03-11	Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
ATE433461T1 (de)	2009-06-15	Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE253117T1 (de)	2003-11-15	Adenovirus e4 proteine für induktion von zelltod
BR0009170A (pt)	2002-04-30	ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
EA199800526A1 (ru)	1999-04-29	Производные бензимидазола и их применение для лечения вирусных инфекций
DE69533873D1 (de)	2005-01-27	Krebstherapie mit lymphotoxin
BR0014372A (pt)	2002-06-25	Derivados de 5-hidroxissapogenina com atividade antidemência
DE69932592D1 (de)	2006-09-14	Rekombinante proteine abgeleitet von hgf und msp
ATE414100T1 (de)	2008-11-15	Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
ATE232398T1 (de)	2003-02-15	Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid
DE69329802D1 (de)	2001-02-01	Syndecan-stimulierung der zellulären differenzierung
DE69814691D1 (de)	2003-06-18	Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten

Legal Events

Date	Code	Title	Description
2007-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties